Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited has announced that its board of directors will meet on August 28, 2025, to review and approve the company’s interim results for the first half of the year and to consider the declaration of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products and related services.
Average Trading Volume: 15,291,215
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.34B
See more data about 3933 stock on TipRanks’ Stock Analysis page.